Implantable Collamer Lens (ICL)

Are you nearsighted?

Not a candidate for LASIK? But looking for a permanent contact lens solution?

Millions of nearsighted Americans may be able to achieve quality vision thanks to the approval by the U.S. Food and Drug Administration of the Visian ICL™ Implantable Collamer Lens. This lens works like an implantable collamer lens and is best suited for individuals who have moderate to severe nearsightedness.

You May Benefit From the EVO ICL

The EVO ICL is an advanced soft-material lens, composed of 100% biocompatible collagen copolymer. It provides permanent vision correction that is sharp and vivid. There is no maintenance associated with the lens, and it is intended to remain in place as long as you are satisfied with your vision. If at any point your vision changes or you wish to have them removed, this can be done easily. Because the cornea is in its natural state, you are able to pursue other vision correction options.

Advantages of ICLs:

  • Treats moderate to high myopia (nearsightedness).
  • Sharp, clear vision with great depth and dimension.
  • Excellent night vision.
  • Great for people with thin corneas.
  • Does not induce dry eye syndrome.
  • No natural corneal tissue is removed or reshaped during implantation.
  • Because ICLs maintain the eye’s structure, measurements required for possible future procedures are easier to identify, increasing the likelihood of positive outcomes. Thus, ICLs mean better and more flexible options for future treatments.
  • UV protection is built into the biocompatible lenses. Long-term or intense exposure to UV radiation can damage eyes, increasing the chance of eye disorders such as cataracts and some retinal problems.
  • 99% patient satisfaction
  • Over 1 million procedures performed worldwide
  • Quick results
  • Can be removed if needed

Schedule an Appointment
LASIK Self-Test
Cataract Self-Test
Contact Us
WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.